Exp Physiol 89.4 pp [417] [418] [419] [420] [421] [422] [423] [424] [425] putative CFTR inhibitor, which was found to effectively inhibit CFTR conductance in the submicromolar range in cultured cells (Ma et al. 2002) . This inhibitor, phenyl]-5-[(4-carboxyphenyl) methylene]-2-thioxo-4-thiazolidinone, termed CFTR Inh -172, blocked the CFTR Cl − conductance expressed in Fischer rat thyroid (FRT) cells with an IC 50 of about 300 nm, but at 5 mm it did not affect a Ca 2+ -activated Cl − channel in human bronchial epithelial cells or a volumeactivated Cl − channel in FRT cells (Ma et al. 2002) . As CFTR functions in both secretory and absorptive capacities, we sought to determine the effect of CFTR Inh -172 on the function of CFTR natively expressed in a purely absorptive human epithelium, the microperfused human sweat duct.
Methods

Tissue source
Sweat ducts were isolated by micro dissection from full thickness skin biopsies 3 mm in diameter taken from young male volunteer subjects who had given written informed consent. Harvested skin tissue was used immediately or stored in Ringer solution at 4
• C until used experimentally (usually within a few hours, but always within 36 h).
Dissection procedures
Segments of sweat ducts of 1-3 mm in length were identified and isolated from single intact glands harvested by microdissection from the subdermis of the skin.
Microperfusion
Duct segments were then cannulated with doublebarrelled microperfusion pipettes so that constant current, 0.5 s pulses, of 50 nA could be passed through one barrel while the transepithelial voltage was measured simultaneously through the other. Luminal perfusing solutions were changed as needed through the voltagemeasuring pipette (Quinton, 1986) .
Solutions
The luminal and bath Ringer solutions contained (mm): NaCl 140, KCl 5, NaH 2 PO 4 3, MgSO 4 1.2, and CaCl 2 1.0. All perfusion solutions were adjusted to pH 7.4 with 1.0 m NaOH. Na + conductance was eliminated in the apical membrane, by adding 10 µm amiloride to luminal solutions or replacing Na + by K + as needed. To impose defined Cl − gradients, Cl − was replaced by equimolar concentrations of gluconate in the perifusion or perfusion solutions as needed.
In order to expose the cytosolic surface of the apical membrane directly to the inhibitor, the basilateral membrane (BLM) of the duct was permeabilized by exposure to approximately 2000 units ml −1 of α-toxin from Staphylococcus aureus (CN Biosciences Inc., CA, USA) for 15-20 min (Reddy & Quinton, 1996) . The Ca 2+ in all Ringer solutions used to perfuse the cytosol was buffered to 80 nm free Ca 2+ with 2.0 mm EGTA. The pH of these solutions was adjusted to pH 6.8 with 1.0 m KOH, and NaCl and sodium gluconate were replaced by equimolar concentrations of their K + salts. After permeabilization, adding 0.1 mm cAMP plus 5 mm ATP to the cytosolic bath reactivated CFTR. To test the effects of CFTR Inh -172 on phosphorylation of CFTR, CFTR was stably phosphorylated by adding cAMP in the presence of ATP-γ -S (5 mm) and okadaic acid (1 µm).
CFTR Inh -172 was carried in a stock solution of DMSO at 25 mm and added to a final aqueous concentration of 5 µm in the perfusion solutions as needed. Aqueous solutions become saturated at 5 µm (A. Verkman, personal communication). Since complete inhibition of G Cl was never observed, even at the saturated concentration of 5 µm, this concentration was used in all protocols. The inhibitor was a generous gift from Dr Alan Verkman, UC San Francisco.
Statistics
The degree of statistical significance was determined from the Student's t test for paired means of values for preand post application of the inhibitor and unpaired means as appropriate. Probability values of less than 0.05 for means were considered to be significantly different. All potentials and conductances are reported as mV and mS cm −2 , respectively.
Results
Intact ducts
In ducts microperfused and perifused with symmetrical, isotonic Ringer solution, there was a significant (P < 0.05) hyperpolarization of the transepithelial potential (V t ) of nearly −30 mV (from −15 to −43 mV) when CFTR Inh -172 was applied in the bath to the contra luminal membrane. Simultaneously, the transepithelial conductance (G t ) fell by almost 50 mS cm −2 (from 82 to 34 mS cm −2 or 58%). However, it was somewhat surprising that there was only Fig. 1 ).
As depolarization with apical application was unexpected (simple loss of G Cl should have hyperpolarized V t ; Quinton, 1983) , we tested whether the decrease in V t might be due to CFTR Inh -172 inhibition of Na + transport. We bilaterally replaced Cl − by the impermeant anion gluconate to remove any effects of G Cl and applied CFTR Inh -172 from the lumen (Fig. 2) . The mean V t decreased from −33 to −25 mV, and G t fell by 21%. On the other hand, when applied from the contra luminal side (Fig. 2) , neither V t nor G t was significantly altered (Table 2) .
To better visualize the inhibitory effects of CFTR Inh -172 on G Cl in the apical membrane and to examine potential effects of membrane polarization on inhibitor efficacy, we imposed steep Cl − diffusion gradients in both directions across the epithelium by replacing Cl − by gluconate first in the lumen and then in the bath. After applying CFTR Inh -172 to the luminal surface, when the Cl − gradient was from bath to lumen, the mean V t depolarized from −75 to −54 mV (28%) and the mean G t fell by 27% (Table 3 ; Fig. 3 ). When the gradient was reversed, the V t decreased from +31 to −1 mV and G t fell by 48% (Table 4) .
We then applied CFTR Inh -172 to the contra luminal side of the duct epithelium in the bath and again tested the effect of membrane polarization on inhibitory efficacy. We found that when the Cl − gradient was from bath to lumen, the mean V t depolarized from −58 to −45 mV and G t fell by 27% (Table 3) . When the gradient was reversed, the mean V t completely reversed polarity from +27 mV to −22 mV and G t fell by 51% (Table 4 ; Fig. 3 ).
Permeabilized ducts
In order to determine whether CFTR Inh -172 could permeate the basilateral membrane and inhibit apical membrane CFTR from its cytoplasmic surface, we applied CFTR Inh -172 to BLM permeabilized ducts to ensure that the inhibitor had access to the cytosolic surface of the membrane. Normally, after permeabilization with α-toxin, CFTR conductance in the apical membrane becomes nil, but can be restored by phosphorylation in the presence of cAMP and ATP (Reddy & Quinton, 1992) . Therefore, after activating CFTR with cAMP (10 µm) and ATP (5 mm), we tested the application of CFTR Inh -172 on each side of the membrane in the presence of a bath-tolumen Cl − gradient. The possibility of a confounding effect from Na + conductance (G Na ) was avoided by replacement of Na + by K + in all solutions and/or by adding amiloride (10 µm) to the luminal perfusate. When CFTR Inh -172 was applied in the luminal perfusate, the potential across the apical membrane (V A ) fell from 40 to 29 mV and G t decreased by 41%. When CFTR Inh -172 was added to the cytosolic bath, V A fell from 54 to 21 mV and the apical conductance (G A ) decreased by 73% (Table 5) .
CFTR Inh -172 was equally effective in inhibiting CFTR that was stably phosphorylated or 'locked open' by prior stimulation of endogenous protein kinase A (PKA) with cAMP (10 µm) in the presence of ATP-γ -S (5 mm) and the phosphatase inhibitor okadaic acid (1 µm).
Discussion
Properties of the sweat duct model for drug testing
The sweat duct should be an excellent model for testing the effects of drugs on CFTR function since it naturally expresses possibly the highest known density of CFTR channels in its apical membrane (Cohn et al. 1991; Kartner et al. 1992) . It also expresses a high CFTR Cl − conductance in its basal membrane (Reddy & Quinton, 1989b) . Its reabsorptive function is crucially dependent on CFTR as demonstrated by the hereditary disease cystic fibrosis, in which the channel is defective. Furthermore, the apical membrane appears to be characterized by only two ion conductances, a Na + conductance through the epithelial Na + channel (ENaC) and a Cl − conductance through CFTR (Bijman & Quinton, 1987; Reddy & Quinton, 1989a,b) . Similarly, the basilateral membrane is characterized mainly by a Figure 1 . Effect of CFTR Inh -172 applied on the luminal and basilateral side of the intact sweat duct After application in the luminal perfusate, in contrast to expectations for blocking the G Cl independently of G Na , V t did not hyperpolarize, but G t fell, suggesting simultaneous inhibition of both G Na and G Cl in the luminal membrane. In contrast, when applied on the serosal side, V t hyperpolarized markedly suggesting that blocking G Cl in the BLM unmasked its K + potential. The lumen (L) and bath (B) of the ducts were perfused continuously with NaCl-containing Ringer solution, except as indicated initially when the lumen contained sodium gluconate (Glu). A, trace shows that completely removing Cl − from the tissue by replacing luminal Cl − by gluconate, depolarized V t from about −73 mV to about −50 mV, which should reflect the potentials due to Na+ transport alone. Adding CFTR Inh -172 (5 µM) to the luminal solution further depolarized V t to about −35 mV suggesting that the inhibitor also blocked G Na . Further addition of amiloride, essentially abolished V t . B, when CFTR Inh -172 (5 µM) was added to the bath side alone, virtually no effect was seen on the Na + transport potential. The bath (B) and lumen (L) were continuously perfused with sodium gluconate except as indicated: Cl (NaCl), 172 (CFTR Inh -172), Amil (amiloride). The differences ( ) between pre-and post application values are shown along with the statistical probability of their significance. CFTR Inh -172 had no significant (P > 0.05) effect when applied to the basilateral side on either V t or G t . NaGlu, sodium gluconate.
K + and a Cl − conductance (Reddy & Quinton, 1991) so that the effects of the inhibitor on CFTR can be studied in virtual isolation from other conductances. In isotonic NaCl Ringer solution, microperfused ducts from normal subjects generally exhibit a spontaneous transepithelial potential difference of about −10 ± 5 mV (lumen negative with respect to contra luminal bath) with a constitutively high Cl − -dependent transepithelial conductance of about 100 mS cm −2 (Quinton, 1986) . The fact that the sweat duct in patients with cystic fibrosis has virtually no Cl − conductance provides a unique and excellent model to compare and evaluate the effects of conductance inhibitors on native functioning human CFTR. Ducts from patients with cystic fibrosis that inherently express dysfunctional CFTR also exhibit spontaneous lumen negative potentials of −60 to −110 mV (Quinton & Bijman, 1983 ) and a G t of only about 15 mS cm −2 (Quinton, 1986) . If Cl − in solutions perfusing normal ducts is replaced by an impermeant anion such as gluconate, the transepithelial potential strongly hyperpolarizes in the direction of the Cl − diffusion gradient and G t falls markedly; however, cystic fibrosis ducts are largely unresponsive to these imposed gradients (Quinton, 1986; Quinton & Reddy, 1989) . This is to say that efficient, specific pharmacological inhibition of CFTR conductance should 'convert' the normal duct to a cystic fibrosis duct; that is, inhibition of normal anion conductance should mimic the native state of ducts from cystic fibrosis patients.
Limitations
While the preparation demonstrates many advantages, it is limited in its ability to render absolute measures of the The differences ( ) between pre-and post application values are shown along with the statistical probability of their significance. At a level of P ≤ 0.02, CFTR Inh -172 had a significant (P ≤ 0.05) effect on both V t and G t when applied to either surface. NaGlu, sodium gluconate.
specific conductance of the tissue. This limitation derives mainly from the variations among the duct tubules and the strict theoretical dependence of the mathematical solution for tissue conductance on the diameter of the lumen. The specific resistance of the duct epithelium was calculated from the cable equation for determining the electrical resistance of an isolator surrounding a conductive core. In our case, the isolator is the duct tubular epithelium and the core is the conductive luminal perfusate (Greger, 1981) . Due to the inability to precisely measure the luminal diameter (12-20 µm) of the intact tubule under transmitted light, precision is not better than ± 1-2 µm in measuring the luminal diameter, which results in some uncertainty of the measure of G t . On the other hand, the measure of V t depends only on the electrochemical forces and permeability properties of the membrane. As such, it is independent of structural variations. Therefore, measured changes in V t may be a more consistent index of changes in G Cl than measured changes in G t .
Effects of CFTR 1nh -172 on salt transport
We were surprised to find that application of CFTR Inh -172 to the lumen of the normal sweat duct had no significant, detectable effect (Table 1 ; Fig. 1 Na + transport activity, we examined the effects of the inhibitor on the duct in the absence of Cl − (replaced by gluconate). With bilateral sodium gluconate, no G Cl or transepithelial electrolyte diffusion gradient exist so that V t reflects the underlying electromotive forces for Na + absorption driven by active transport (essentially the sum of the apical membrane Na + EMF and the basilateral K + EMF). Under these conditions, when added to the luminal perfusate, both V t and G t fell significantly (25% and 21%, respectively; Table 2 ; Fig. 2 ) and when added to the bath, neither value was affected. These results suggest that in addition to CFTR, the inhibitor may have an inhibitory effect on active Na + transport by blocking ENaC from the luminal side.
We have shown previously that G Na depends upon a functioning, conductive CFTR, so that if G Cl is inhibited, we might expect G Na to fall accordingly. The partial loss of conductances from both Na + and Cl − pathways would have less apparent effect on membrane selectivity and voltage than if G Na remained independent of G Cl . This prediction seems consistent with the present results of decreased overall ductal conductance without a significant change in V t after luminal application of CFTR Inh -172 in bilateral NaCl with no transepithelial ion gradients present. This result and explanation assumes that the inhibitor may be relatively less permeable through the apical membrane.
In contrast, bath application of CFTR Inh -172 to the basilateral surface caused striking hyperpolarization of the epithelium in bilateral NaCl Ringer solution. In this case the hyperpolarization of V t may be explained by shifting the BLM to a predominantly K + -selective membrane. Blocking G Cl in the BLM should hyperpolarize this membrane by shifting it towards the K + equilibrium potential (Reddy & Quinton, 1991) . Since V t is the difference between basal membrane voltage (V b ) and V A , the loss of BLM G Cl is reflected in a much more negative V t . Moreover, the results in the permeabilized duct suggest that CFTR Inh -172 is more effective from the cytosolic side. Of course, we cannot exclude the (likely) possibility that the inhibitor permeates the BLM of non-permeabilized ducts and not only blocks the G Cl in the BLM, but also blocks the apical membrane CFTR G Cl from the cytosolic surface. Still, while this may be the case, complete inhibition is not realized because the hyperpolarization of V t due to the inhibitor was low compared to what we expect for a near complete block of both membranes as exemplified by cystic fibrosis ducts lacking CFTR. Cystic fibrosis ducts bathed in bilaterally NaCl spontaneously exhibit V t of ca −75 mV (Quinton, 1983) compared to the mean V t of −43 mV seen here after adding CFTR Inh -172 to the bath.
Effects of polarization on CFTR Inh -172 inhibition
We then questioned whether the electrical polarity of the membrane might affect the inhibitor's ability to interact with CFTR. As CFTR G Cl is large and constitutively open in the intact duct, the bath-to-lumen Cl − diffusion potential markedly hyperpolarized V t (−10 to −75 mV, lumen negative). Application of CFTR Inh -172 to the duct lumen or to the bath depolarized the diffusion potential to about the same degree and decreased G t by about the same amount ( Table 3 ), suggesting that under these conditions the effect was about equal on either side of the tissue. The differences ( ) between pre-and post application values are shown along with the statistical probability of their significance. At a level of P ≤ 0.05, CFTR Inh -172 had a significant effect on both V t and G t when applied to either surface.
We then reversed the Cl − diffusion gradient by replacing Cl − in the bath by gluconate. When CFTR Inh -172 was added to either the lumen or the bath, V t hyperpolarized and G t also fell about equally (Table 4) . As the inhibitory effect was about equal with application to either the cytosolic or luminal surface under polarized and depolarized conditions (P > 0.05), we surmise that there is little, if any, electrostatic effects on drug distribution. That is, electrical gradients, which favoured carrying a higher (or lower) concentration of the inhibitor (negative charged) into the membrane, did not appear to alter its effect.
Even so, the results seem to suggest that the inhibitory effect is larger when Cl − is in the lumen (Tables 3 and  4 ). The apparently larger effects with luminal Cl − may be simply due to higher diffusion potentials and larger conductances that are present with Cl − in the lumen.
Effect of CFTR Inh -172 on the cytosolic membrane surface
To examine the effectiveness of the inhibitor on the cytosolic surface of CFTR, we applied the inhibitor alternately to the apical surface and then to the cytosolic surface of basilaterally permeabilized ducts after activating CFTR with cAMP and ATP. In the presence of a lumento-cytosol Cl − gradient of 150 mm, luminal CFTR Inh -172 reduced V A by 11 mV and G A by 7 mS cm −2 . The inhibitor seemed somewhat more effective when applied to the cytosolic side, reducing V A by 32 mV and G A by 16 mS cm −2 . The differences ( ) between pre-and post application values are shown along with the statistical probability of their significance. CFTR Inh -172 had a significant effect on both V t and G t when applied to either surface. BLM, basilateral membrane; KGlu, potassium gluconate (P ≤ 0.05).
Time course and reversibility
Inhibition of CFTR G Cl with CFTR Inh -172 was relatively slow, requiring more than 10 min to read half-maximal effect (T 1/2 = 3.1 ± 0.4 min) to approach maximal effect. Likewise, even though the inhibition appears to be highly, if not fully reversible, washout required an even longer time course (T 1/2 = 17.0 ± 2.6 min; Figs 1, 3 and 4 show traces of V t and V A revealing the slow inhibitory effect and slow reversibility). These rates of action seem similar to those first reported for transfected FRT cells (Ma et al. 2002) .
Effect on phosphorylation
CFTR Inh -172 might inhibit the phosphorylation activation of the Cl − channel instead of CFTR itself. However, this appears not to be the case. At least, if CFTR Inh -172 inhibits phosphorylation, it must also directly inhibit CFTR as well. If its only action were to inhibit phosphorylation, it is unlikely that CFTR Inh -172 would have inhibited CFTR after it had been stably phosphorylated and its endogenous phosphatases blocked with okadaic acid ; however, it did (Fig. 4) .
Relative effectiveness
At its aqueous saturated concentration of 5 µm, CFTR Inh -172 appears to block as much as 70% of CFTR G Cl when applied to the cytosolic side of the membrane (Table 5 ; Fig. 4 ). Its inhibitory efficacy from the luminal surface may be less, although it seemed equally effective on either side of the intact duct when Cl − gradients were present. Even so, it is encouraging that compared to previously examined inhibitors of G Cl in the sweat duct, CFTR Inh -172 appears to be a more potent blocker. We note that bumetanide and DIDS required 1 mm (also near saturation points) or nearly 20 times the concentration of CFTR Inh -172 used here to block 85% and 70% of CFTR G Cl , respectively. These inhibitors were also most effective from the cytosolic side. Other commonly used anion conductance inhibitors were even less potent (Reddy & Quinton, 1999) . Lastly, we note with some consternation that the inhibitory effects seen here in native tissue are not nearly as complete as they appeared to be in amphotericin B-permeabilized FRT monolayers. The inhibition of Cl − conductance was reflected by the virtual short circuit current (I sc ) that arose after a 2:1 Cl − gradient (150:75 mm) was imposed across the cells. The current was monitored as a function of inhibitor concentrations up to 5 µm where virtual current was almost completely blocked. It is not clear why CFTR in cultured cells should be more sensitive than in native tissue. On the other hand, in non-permeabilized primary cultures of human bronchial epithelial cells, blocked with amiloride, the putative Figure 4 . Lack of effect of stably phosphorylating CFTR on CFTR Inh -172 inhibition A, effect of the inhibitor on CFTR activated by cAMP (10 µM) + ATP (5 mM) on the cytoplasmic side of the apical membrane after α-toxin induced permeabilization of the basilateral membrane. B, similar experiment, except that CFTR was stably phosphorylated by prior cAMP-dependent phosphorylation in the presence of ATP-γ -S (5 mM). After activating CFTR Cl − conductance by adding ATP, CFTR Inh -172 continued to effectively inhibit CFTR Cl − conductance, indicating that it may act directly on CFTR. The ducts were continuously perfused with NaCl and amiloride (10 µM) in the lumen and potassium gluconate and the phosphatase inhibitor, okadaic acid (1 µM) in the bath.
secretory current appeared to be reduced from about 10 to 3 µA (ca 70%; see Figure 3b in Ma et al. 2002) , which is more in line with our findings here. However it is interesting that in contrast to the sweat duct, CFTR Inh -172 seemed to be more effective from the apical than from the basal surface in bronchial cells. This difference may be related to the secretory function of bronchial cells, which presumably exhibit CFTR only in the apical membrane compared to the exclusively absorptive function of the duct, which exhibits CFTR in both membranes.
Conclusion
Overall, CFTR Inh -172 blocks CFTR G Cl in the apical and basal membrane of the human reabsorptive sweat duct and probably does so by direct interaction. Unfortunately, the limited solubility of CFTR Inh -172 prevents determination of a maximal inhibitory effect. CFTR Inh -172 may be useful in identifying Cl − channels, particularly if it proves to be highly selective for CFTR. However, it suffers from a low aqueous solubility, slow interaction and reversibility rates, and possible effects on Na + transport.
